![Frank Weber](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Weber
Chief Executive Officer at
VIVORYON THERAPEUTICS N.V.
Net worth: 248 417 $ as of 31/05/2026
Profile
Dr. Frank T.
Weber, MD, is a CEO, Executive Director & Chief Medical Officer at Vivoryon Therapeutics NV.
He is on the Board of Directors at Vivoryon Therapeutics NV and Zambon Biotech SA. Dr. Weber was previously employed as a Chief Medical & Development Officer by Spexis Ltd., a Senior Vice President-European Medical Division by InterMune International AG, a Medical Director by MedNet GmbH, a Chief Medical Officer by Merck KGaA, and a Chief Medical Officer by Merck Serono SA. He received his doctorate degree from Universität zu Köln.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/04/2026 | 168,950 ( 0.57% ) | 248 417 $ | 31/05/2026 |
Frank Weber active positions
| Companies | Position | Start |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Chief Executive Officer | 14/08/2023 |
Former positions of Frank Weber
| Companies | Position | End |
|---|---|---|
| MERCK KGAA | Chief Tech/Sci/R&D Officer | - |
InterMune International AG
 InterMune International AG Miscellaneous Commercial ServicesCommercial Services Leases nonfinancial intangible assets | Corporate Officer/Principal | - |
Merck Serono SA
 Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Chief Tech/Sci/R&D Officer | - |
MedNet GmbH
 MedNet GmbH Medical DistributorsDistribution Services Wholesales medical devices and semi-finished products | Corporate Officer/Principal | - |
| SPEXIS AG | Chief Tech/Sci/R&D Officer | - |
Training of Frank Weber
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Universität zu Köln
 Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spexis Ltd.
 Spexis Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that focuses on the discovery and development of macrocycle drugs addressing unmet medical needs | Health Technology |
Merck Serono SA
Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Health Technology |
Vivoryon Therapeutics NV
 Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
MedNet GmbH
MedNet GmbH Medical DistributorsDistribution Services Wholesales medical devices and semi-finished products | Distribution Services |
InterMune International AG
InterMune International AG Miscellaneous Commercial ServicesCommercial Services Leases nonfinancial intangible assets | Commercial Services |
- Stock Market
- Insiders
- Frank Weber
